TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
KLRA

Kailera Therapeutics, Inc.

Healthcare · Biotechnology

10.00$ -5.0% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet KLRA
Line item Q1 26 Q2 26
100.0% 100.0%
84.9% 76.7%
17.9% 10.8%
83.1% 75.7%
0.5% 0.5%
169.2% 7.7%
8.8% 6.9%
0.2% 0.1%
1.1% 1.6%
-69.2% 92.3%
-71.6% -46.1%
18.9% 8.4%

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?